Migraine sufferers have a new ally in their fight against debilitating headaches. Anti-CGRP monoclonal antibodies are becoming a go-to choice for preventing migraines. These drugs work by targeting a specific pathway in the body involved in migraine attacks. But how well do patients stick with these
Fluoxetine, a widely used antidepressant, has been under the microscope. Researchers took a deep dive into the FAERS database. This database is a treasure trove of information. It collects reports of side effects from medications used in real-world settings. The goal? To spot any unexpected or harmf
Von Willebrand disease (VWD) is a bleeding disorder that affects how blood clots. A recent study looked at a new treatment called pdVWF/FVIII-C. This treatment is made from plasma and contains two important clotting factors: von Willebrand factor and factor VIII. The study followed 15 patients with
A new drug, upadacitinib, has been making waves in the treatment of severe eczema, also known as atopic dermatitis (AD). This medication is a Janus kinase (JAK) inhibitor, which means it stops certain enzymes from causing inflammation. It's been approved for kids aged 12 and above who have moderate
Meet rimegepant, a new drug that blocks certain signals in your brain to stop migraines. It's been tested in labs and found to work, but what about in the real world? That's what the GAINER study set out to find. This study, happening in multiple places, looked at how well rimegepant works and how t
Isavuconazole, a newer type of antifungal drug, has been making waves in the medical world. Recently, researchers dug into real-world reports to check how safe it really is. They looked at databases from various places where people had reported any side effects. The goal? To give doctors a clearer p
Ever heard of myelodysplastic syndromes (MDS)? It's a condition where your body can't make enough healthy red blood cells, leading to anemia and a need for blood transfusions. A new drug, luspatercept, has been showing great promise in clinical trials. But how does it fare in the real world? A study
